H.R. 679

Title:  To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Sponser: Harshbarger, Diana [Rep.-R-TN-1] (Introduced 01/23/2025)
Latest Action:
Permanent Link:
pdf:
html:
txt:

01/23/2025

119th Congress (2025-2026)

https://www.congress.gov/bill/119th-congress/house-bill/679

Category:

Leave the first comment